30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Journey Medical Corp (DERM)

Track

The most recent insider trading activity occurred on May 2, 2025, with multiple executives, including the President & CEO, COO, and CFO, selling shares. Prior to this, significant selling by the President & CEO was observed in early March 2025. The last reported insider buy transaction was on March 22, 2024.
Stock chart
Ticker: DERM Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Maraoui Claude
President & CEO
1 sale — total 33,065 USD
Sale 2 May 2025
Value US$266,585.50 | Price 356.99 | Shares 53,762
Sale 2 May 2025
Value US$1,139,254.64 | Price 310.55 | Shares 49,753
Sale 2 May 2025
Value US$16,477.56 | Price 6.84 | Shares 2,409
Sale 11 Mar 2025
Value US$246,847.71 | Price 5.01 | Shares 49,271
Sale 7 Mar 2025
Value US$74,674.05 | Price 5.01 | Shares 14,905
Sale 6 Mar 2025
Value US$128,777.04 | Price 5.04 | Shares 25,551
Sale 5 Mar 2025
Value US$93,094.11 | Price 5.13 | Shares 18,147
Sale 4 Mar 2025
Value US$145,661.04 | Price 5.04 | Shares 28,901
Sale 3 Mar 2025
Value US$122,006.52 | Price 5.19 | Shares 23,508
Sale 21 Feb 2025
Value US$7,084.35 | Price 5.19 | Shares 1,365
Sale 1 Aug 2024
Value US$51,002.28 | Price 5.47 | Shares 9,324
Sale 23 Jul 2024
Value US$21,897.00 | Price 5.40 | Shares 4,055
Buy 25 Mar 2024
Value US$30,400.00 | Price 3.04 | Shares 10,000
Buy 22 Mar 2024
Value US$104,100.00 | Price 3.47 | Shares 30,000
Buy 22 Mar 2024
Value US$34,790.00 | Price 3.48 | Shares 10,000
Buy 22 Mar 2024
Value US$68,000.00 | Price 3.40 | Shares 20,000
Sale 22 Feb 2024
Value US$9,187.50 | Price 3.75 | Shares 2,450
Sale 28 Nov 2023
Value US$9,108.90 | Price 5.22 | Shares 1,745
Sale 8 Nov 2023
Value US$958.80 | Price 3.76 | Shares 255
Sale 7 Nov 2023
Value US$7,812.60 | Price 3.48 | Shares 2,245
Buy 13 Oct 2023
Value US$98,340.00 | Price 2.98 | Shares 33,000
Buy 6 Oct 2023
Value US$44,700.00 | Price 2.98 | Shares 15,000
Buy 21 Sep 2023
Value US$89,100.00 | Price 2.97 | Shares 30,000
Buy 6 Sep 2023
Value US$223,000.00 | Price 2.23 | Shares 100,000
Buy 6 Sep 2023
Value US$65,630.88 | Price 2.52 | Shares 26,044
Sale 24 Jul 2023
Value US$36,549.92 | Price 1.76 | Shares 20,767
Sale 24 Jul 2023
Value US$7,166.72 | Price 1.76 | Shares 4,072
Sale 17 May 2023
Value US$32,665.18 | Price 1.34 | Shares 24,377
Sale 16 May 2023
Value US$25,000.00 | Price 1.25 | Shares 20,000
Sale 22 Feb 2023
Value US$5,452.96 | Price 1.97 | Shares 2,768
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-05 2025-05-02 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
53,762 -27.4%
356.99
US$266,585 		53,762 -27.4% 356.99 US$266,585
2025-05-05 2025-05-02 S Sale
0.9
Alloush Ramsey

COO

Officer
49,753 +30.1%
310.55
US$1,139,255 		49,753 +30.1% 310.55 US$1,139,255
2025-05-05 2025-05-02 S Sale
2.8
Benesch Joseph

CFO

Officer
61,793 -15.0%
384.86
US$3,625,028 		61,793 -15.0% 384.86 US$3,625,028
2025-03-11 2025-03-11 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
49,271 -2.4%
5.01
US$246,848 		49,271 -2.4% 5.01 US$246,848
2025-03-10 2025-03-07 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
14,905 -0.7%
5.01
US$74,674 		14,905 -0.7% 5.01 US$74,674
2025-03-10 2025-03-06 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
25,551 -1.2%
5.04
US$128,777 		25,551 -1.2% 5.04 US$128,777
2025-03-05 2025-03-05 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
18,147 -0.9%
5.13
US$93,094 		18,147 -0.9% 5.13 US$93,094
2025-03-05 2025-03-04 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
28,901 -1.4%
5.04
US$145,661 		28,901 -1.4% 5.04 US$145,661
2025-03-05 2025-03-03 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
23,508 -1.1%
5.19
US$122,007 		23,508 -1.1% 5.19 US$122,007
2025-02-24 2025-02-21 S Sale
2.8
Benesch Joseph

CFO

Officer
1,365 -2.9%
5.19
US$7,084 		1,365 -2.9% 5.19 US$7,084
2024-08-01 2024-08-01 S Sale
2.8
Benesch Joseph

CFO

Officer
9,324 -16.5%
5.47
US$51,002 		9,324 -16.5% 5.47 US$51,002
2024-07-23 2024-07-23 S Sale
2.8
Benesch Joseph

CFO

Officer
4,055 -6.7%
5.40
US$21,897 		4,055 -6.7% 5.40 US$21,897
2024-03-27 2024-03-25 B Purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
10,000 +7.4%
3.04
US$30,400 		10,000 +7.4% 3.04 US$30,400
2024-03-25 2024-03-22 B Purchase
3.8
Smith Justin Adam
Non-Executive Director
30,000 +28.6%
3.47
US$104,100 		30,000 +28.6% 3.47 US$104,100
2024-03-25 2024-03-22 B Purchase
2.7
Maraoui Claude

President & CEO

Executive Director
10,000 +0.5%
3.48
US$34,790 		10,000 +0.5% 3.48 US$34,790
2024-03-25 2024-03-22 B Purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
20,000 +17.5%
3.40
US$68,000 		20,000 +17.5% 3.40 US$68,000
2024-02-23 2024-02-22 S Sale
2.8
Benesch Joseph

Interim CFO

Officer
2,450 -3.9%
3.75
US$9,188 		2,450 -3.9% 3.75 US$9,188
2023-11-29 2023-11-28 S Sale
3.5
Paley Jeffrey
Non-Executive Director
1,745 -2.4%
5.22
US$9,109 		1,745 -2.4% 5.22 US$9,109
2023-12-08 2023-11-08 S Sale
3.5
Paley Jeffrey
Non-Executive Director
255 -0.2%
3.76
US$959 		255 -0.2% 3.76 US$959
2023-12-08 2023-11-07 S Sale
3.5
Paley Jeffrey
Non-Executive Director
2,245 -1.9%
3.48
US$7,813 		2,245 -1.9% 3.48 US$7,813
2023-10-17 2023-10-13 B Purchase
3.8
Smith Justin Adam
Non-Executive Director
33,000 +46.0%
2.98
US$98,340 		33,000 +46.0% 2.98 US$98,340
2023-10-10 2023-10-06 B Purchase
3.5
Paley Jeffrey
Non-Executive Director
15,000 +26.1%
2.98
US$44,700 		15,000 +26.1% 2.98 US$44,700
2023-09-25 2023-09-21 B Purchase
3.5
Paley Jeffrey
Non-Executive Director
30,000 +109.2%
2.97
US$89,100 		30,000 +109.2% 2.97 US$89,100
2023-09-08 2023-09-06 B Purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
100,000 +702.0%
2.23
US$223,000 		100,000 +702.0% 2.23 US$223,000
2023-09-08 2023-09-06 B Purchase
2.7
Maraoui Claude

President & CEO

Executive Director
26,044 +1.2%
2.52
US$65,631 		26,044 +1.2% 2.52 US$65,631
2023-07-25 2023-07-24 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
20,767 -1.0%
1.76
US$36,550 		20,767 -1.0% 1.76 US$36,550
2023-07-25 2023-07-24 S Sale
2.8
Benesch Joseph

See Remarks

Officer
4,072 -6.1%
1.76
US$7,167 		4,072 -6.1% 1.76 US$7,167
2023-05-18 2023-05-17 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
24,377 -1.1%
1.34
US$32,665 		24,377 -1.1% 1.34 US$32,665
2023-05-18 2023-05-16 S Sale
2.7
Maraoui Claude

President & CEO

Executive Director
20,000 -0.9%
1.25
US$25,000 		20,000 -0.9% 1.25 US$25,000
2023-02-23 2023-02-22 S Sale
2.8
Benesch Joseph

Interim CFO

Officer
2,768 -4.0%
1.97
US$5,453 		2,768 -4.0% 1.97 US$5,453
Explore more

More insider trading research around Journey Medical Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America